Quiflor
Active substance
ATC code
Species
Dogs.
Indications
Treatment of infections caused by strains of microorganisms susceptible to marbofloxacin in dogs:
- skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis, furunculosis, cellulitis);
- urinary tract infections (UTI) associated or not with prostatitis or epididymitis;
- respiratory tract infections.
Dose to be administered and administration route
For oral administration.
The recommended dose rate is 2 mg marbofloxacin/kg body weight/day (1 tablet for 10 kg body weight per day) in single daily administration. Where appropriate, the use of combinations of whole or half tablets of different strengths (5 mg, 20 mg or 80 mg) will allow accurate dosing.
|
Animal body weight (kg) |
Number of tablets (20 mg + 5 mg strengths) |
Approx. dosage range (mg/kg) |
|
4 – 6 |
0.5 + 0.5 |
2.1 – 3.1 |
|
>6 – 9 |
1 |
2.0 – 3.3 |
|
>9 – 11 |
1 + 1 |
2.3 – 2.8 |
|
>11 – 15 |
1.5 |
2.0 – 2.7 |
|
>15 – 20 |
2 |
2.0 – 2.7 |
|
>20 – 25 |
2.5 |
2.0 – 2.5 |
|
>25 – 30 |
3 |
2.0 – 2.4 |
|
>30 – 35 |
3.5 |
2.0 – 2.3 |
To ensure a correct dosage body weight should be determined as accurately as possible to avoid underdosing.
Duration of treatment:
- in skin and soft tissue infections, treatment duration is at least 5 days and depending on the course of the disease, it may be extended up to 40 days.
- in urinary tract infections, treatment duration is at least 10 days and depending on the course of the disease, it may be extended up to 28 days.
- in respiratory infections, treatment duration is at least 7 days and depending on the course of the disease, it may be extended up to 21 days.
Adverse reactions
Mild side effects such as vomiting, softening of faeces, modification of thirst or transient increase in activity may very rarely occur. These signs cease spontaneously after treatment and do not necessitate cessation of treatment.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
References
Similar products
Showing 3 of 3 results
Quiflor
Quiflor
